Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News ICAD Inc ICAD

iCAD, Inc. provides artificial intelligence-powered cancer detection. Its ProFound Breast Health Suite enables medical providers and professionals to accurately and reliably identify where cancer may be hiding. Its Cancer Detection segment solutions include advanced artificial intelligence and image analysis workflow solutions that enable healthcare professionals to better serve patients by... see more

Recent & Breaking News (NDAQ:ICAD)

5 Stocks To Watch For November 23, 2018

Benzinga.com  November 23, 2018

iCAD Reports Third Quarter 2018 Financial Results

GlobeNewswire November 13, 2018

iCAD Announces Retirement of CEO, Ken Ferry

GlobeNewswire November 9, 2018

iCAD to Report Third Quarter and Nine Months Ended September 30, 2018 Financial Results on Tuesday, November 13th

GlobeNewswire November 6, 2018

Navicent Health Adopts iCAD’s Breast Cancer Detection and Therapy Solutions to Enhance Patient Care

GlobeNewswire October 30, 2018

iCAD Announces New Clinical Data on the Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment Demonstrating Positive Results

GlobeNewswire October 23, 2018

iCAD Announces Exceptional Study Results Demonstrating Significant Advantages of Revolutionary Artificial Intelligence Technology for Digital Breast Tomosynthesis

GlobeNewswire October 11, 2018

SUNY Upstate Medical University Selects iCAD’s Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment

GlobeNewswire October 9, 2018

Sanford Health Announces Adoption of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment

GlobeNewswire October 3, 2018

Independent, Long-Term Study Highlights Effectiveness of iCAD's Xoft Electronic Brachytherapy System for Early-Stage Breast Cancer Treatment

GlobeNewswire October 1, 2018

iCAD Announces AERB Approval of Xoft System in India

GlobeNewswire August 29, 2018

Medical City Plano, a HCA Healthcare Facility, Adopts iCAD’s Xoft Electronic Brachytherapy System for Treatment of Early-Stage Breast Cancer

GlobeNewswire August 28, 2018

Arcturus Therapeutics Appoints Andrew Sassine as Interim Chief Financial Officer

GlobeNewswire August 28, 2018

iCAD Reports Second Quarter 2018 Financial Results

GlobeNewswire August 14, 2018

iCAD Receives FDA Clearance of PowerLook Density Assessment for Digital Breast Tomosynthesis

GlobeNewswire August 8, 2018

iCAD to Report Second Quarter and Six Months Ended June 30, 2018 Financial Results on Tuesday, August 14th

GlobeNewswire August 7, 2018

iCAD Named 2018 MedTech Breakthrough Award Winner

GlobeNewswire June 6, 2018

iCAD Reports First Quarter 2018 Financial Results

GlobeNewswire May 14, 2018

iCAD, Inc. to Host Earnings Call

Accesswire May 14, 2018

iCAD to Report First Quarter 2018 Financial Results on Monday, May 14, 2018

GlobeNewswire May 8, 2018